Table 3.
Histological features after eTHE
| eTHE (n = 166) | |
|---|---|
| Tumor localization, n (%) | |
| Upper third | 1 (0.6) |
| Middle third | 28 (16.9) |
| Distal third | 137 (82.5) |
| AEG Typ I | 101 (73.7) |
| AEG Typ II | 29 (21.2) |
| Tumor entity, n (%) | |
| Squamous carcinoma, n (%) | 46 (27.7) |
| Adenocarcinoma, n (%) | 114 (68.7) |
| Others | 6 (3.6) |
| (y) pT-Stagea | |
| ypT0 | 42 (25.3) |
| (y) pT1 | 46 (27.7) |
| (y)pT2 | 22 (13.3) |
| (y)pT3 | 56 (33.7) |
| N-Stagea | |
| pN0 | 111 (66.9) |
| pN1 | 32 (19.3) |
| pN2 | 16 (9.6) |
| pN3 | 7 (4.2) |
| TNM 8-Stagea | |
| I | 89 (53.6) |
| II | 19 (11.4) |
| IIIA | 15 (9.0) |
| IIIB | 30 (18.1) |
| IVA | 7 (4.2) |
| IVB | 6 (3.6) |
| RO resection | 161 (97.0) |
| No. of resected lymph nodes | 25 (17.0) |
| Complete response (Becker 1a)a | 49 (34.0) |
Values are medians (interquartile ranges) unless indicated otherwise
eTHE extended transhiatal esophageal resection with radical bilateral mediastinal en bloc lymphadenectomy
a Values are numbers (percentages)